Home environment and lung disease progression study
Part of Lungs & breathing clinical trials.
This study looks at whether things in your home might affect how quickly your lung disease gets worse. You and a matched group will be followed to see how your home environment impacts your lung health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have one of these lung conditions: idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, pneumoconiosis, lung disease with autoimmune features, pleuroparenchymal fibroelastosis, chronic hypersensitivity pneumonitis (not caused by your home), stage 4 sarcoidosis with scarring, or an unclassifiable type
- Your lung scarring got worse in the last 12 months (for the case group) or stayed the same (for the control group)
- You live in the Ile-de-France region (around Paris)
- You have lived in your current home for at least 1 year and spend at least 6 months a year there
- You can speak French or have someone who lives with you who can translate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a type of white blood cell called eosinophils in people with interstitial lung disease (a group of conditions that cause lung scarring). It aims to understand if eosinophil levels are linked to the disease, which might help improve future treatments.
This trial looks at different types of lung scarring (called interstitial lung disease) to better understand the condition across all ages. It also includes family members of people with certain genetic mutations that affect the lungs.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This trial looks at whether improving indoor air quality in your home can help your lung health and overall well-being. If you have interstitial lung disease (a condition that makes your lungs stiff and harder to breathe), you might be able to join to see if cleaner air can make a difference.
This study tests whether a special home visit from an indoor environment medical advisor can help people with fibrosing hypersensitivity pneumonitis. The goal is to find and address things in your home that might be making your lung condition worse.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
Hear when a new Assess PID Diagnosis Revision After CMEI Audit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.